Ángel Sesar

900 total citations
32 papers, 453 citations indexed

About

Ángel Sesar is a scholar working on Neurology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Ángel Sesar has authored 32 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Neurology, 7 papers in Cellular and Molecular Neuroscience and 5 papers in Psychiatry and Mental health. Recurrent topics in Ángel Sesar's work include Parkinson's Disease Mechanisms and Treatments (21 papers), Neurological disorders and treatments (18 papers) and Botulinum Toxin and Related Neurological Disorders (11 papers). Ángel Sesar is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (21 papers), Neurological disorders and treatments (18 papers) and Botulinum Toxin and Related Neurological Disorders (11 papers). Ángel Sesar collaborates with scholars based in Spain, Mexico and Germany. Ángel Sesar's co-authors include A. Castro, Marcos Rossi-Izquierdo, José Matías Arbelo, Miguel Gelabert‐González, José Luis Relova, J A Burguera, Pedro Ruiz, Juan Carlos Martínez‐Castrillo, Víctor Puente and M. R. Luquín and has published in prestigious journals such as SHILAP Revista de lepidopterología, Spine and Journal of the Neurological Sciences.

In The Last Decade

Ángel Sesar

28 papers receiving 446 citations

Peers

Ángel Sesar
Pravin Khemani United States
Gian Pal United States
Nawaz Hack United States
Corina Maetzler Germany
Sol De Jesus United States
Alberto Cucca United States
Alfonso Rubino Italy
Samuel Yong‐Ern Ng Singapore
Cecilia Raccagni Austria
Ji Seon Kim South Korea
Pravin Khemani United States
Ángel Sesar
Citations per year, relative to Ángel Sesar Ángel Sesar (= 1×) peers Pravin Khemani

Countries citing papers authored by Ángel Sesar

Since Specialization
Citations

This map shows the geographic impact of Ángel Sesar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ángel Sesar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ángel Sesar more than expected).

Fields of papers citing papers by Ángel Sesar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ángel Sesar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ángel Sesar. The network helps show where Ángel Sesar may publish in the future.

Co-authorship network of co-authors of Ángel Sesar

This figure shows the co-authorship network connecting the top 25 collaborators of Ángel Sesar. A scholar is included among the top collaborators of Ángel Sesar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ángel Sesar. Ángel Sesar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sesar, Ángel, et al.. (2025). A domain-based framework for cognitive profile identification in Parkinson’s disease across diverse samples. Frontiers in Neuroanatomy. 19. 1566835–1566835.
3.
4.
Sesar, Ángel, et al.. (2022). Progression and treatment of a series of patients with advanced LRRK2-associated Parkinson’s disease. Neurología (English Edition). 38(5). 350–356. 2 indexed citations
5.
Sesar, Ángel, et al.. (2021). Continuous subcutaneous apomorphine infusion in the early phase of advanced Parkinson’s disease: A prospective study of 22 patients. Clinical Parkinsonism & Related Disorders. 6. 100129–100129. 17 indexed citations
6.
Sesar, Ángel, et al.. (2021). Do we need to redefine the advanced stage in Parkinson’s disease?. SHILAP Revista de lepidopterología. 22(4). 2 indexed citations
7.
Sesar, Ángel, et al.. (2019). Continuous subcutaneous apomorphine in advanced Parkinson’s disease patients treated with deep brain stimulation. Journal of Neurology. 266(3). 659–666. 18 indexed citations
8.
9.
Sesar, Ángel, et al.. (2017). Delayed complications of deep brain stimulation: 16-year experience in 249 patients. Acta Neurochirurgica. 159(9). 1713–1719. 35 indexed citations
10.
Sesar, Ángel, Pilar Cacheiro, Marisol López, et al.. (2016). Synaptotagmin XI in Parkinson's disease: New evidence from an association study in Spain and Mexico. Journal of the Neurological Sciences. 362. 321–325. 18 indexed citations
11.
Rossi-Izquierdo, Marcos, Andrés Soto-Varela, Arne Ernst, et al.. (2016). What Could Posturography Tell Us About Balance Problems in Parkinson's Disease?. Otology & Neurotology. 37(9). e326–e331. 7 indexed citations
12.
Sesar, Ángel, et al.. (2016). Bilateral pallidal deep brain stimulation in myoclonus-dystonia: our experience in three cases and their follow-up. Acta Neurochirurgica. 158(10). 2023–2028. 14 indexed citations
13.
Fachal, Laura, Ana Mosquera‐Miguel, Pau Pástor, et al.. (2014). No evidence of association between common European mitochondrial DNA variants in Alzheimer, Parkinson, and migraine in the Spanish population. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 168(1). 54–65. 39 indexed citations
14.
Kulisevsky, Jaime, M. R. Luquín, José Matías Arbelo, et al.. (2013). Enfermedad de Parkinson avanzada. Características clínicas y tratamiento. Parte II. Neurología. 28(9). 558–583. 32 indexed citations
15.
Kulisevsky, Jaime, M. R. Luquín, José Matías Arbelo, et al.. (2013). Enfermedad de Parkinson avanzada. Características clínicas y tratamiento (parte I). Neurología. 28(8). 503–521. 35 indexed citations
16.
Kulisevsky, Jaime, M. R. Luquín, José Matías Arbelo, et al.. (2013). Advanced Parkinson's disease: Clinical characteristics and treatment (part 1). SHILAP Revista de lepidopterología. 28(8). 503–521. 47 indexed citations
17.
Sesar, Ángel, José Matías Arbelo, & J López del Val. (2011). Treatment of Parkinson Disease, Time and Dosage. The Neurologist. 17(6 Suppl 1). S43–S46. 9 indexed citations
18.
Rossi-Izquierdo, Marcos, et al.. (2009). A Prospective Study of Alterations in Balance among Patients with Parkinson’s Disease. European Neurology. 61(3). 171–176. 60 indexed citations
19.
Arias, Manuel, et al.. (2007). The autoscopic phenomena in neurological clinic: A study of two cases. Journal of the Neurological Sciences. 263(1-2). 223–225. 9 indexed citations
20.
Arias, Manuel, et al.. (2004). Acute Spinal Epidural Hematoma and Systemic Mastocytosis. Spine. 29(8). E161–E163. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pravin Khemani Breakdown of academic impact, for papers by Gian Pal Breakdown of academic impact, for papers by Nawaz Hack Breakdown of academic impact, for papers by Corina Maetzler Breakdown of academic impact, for papers by Sol De Jesus Breakdown of academic impact, for papers by Alberto Cucca Breakdown of academic impact, for papers by Alfonso Rubino Breakdown of academic impact, for papers by Samuel Yong‐Ern Ng Breakdown of academic impact, for papers by Cecilia Raccagni Breakdown of academic impact, for papers by Ji Seon Kim
Rankless by CCL
2026